• Newsletter
• Contact
• Careers
• Calendar
• RFP
• Français
• myGAVI
• Donate

• Home
• About the Alliance
  • Learn more about GAVI
  • GAVI's mission
    • What we do
    • GAVI's impact
    • Challenges and opportunities
    • Healthy girls, healthy women
    • Gender and immunisation
    • Why invest in GAVI?
    • Advocates
  • GAVI's strategy
  • Value of vaccination
  • GAVI's partnership model
  • GAVI's business model
  • Global health and development
  • Governing GAVI
    • GAVI Board
    • GAVI Secretariat
    • GAVI Internal Audit
    • Programmatic and Finance Policies
    • Corporate Policies
• Types of support
  • What GAVI offers and how it works
  • Apply for support
  • New and underused vaccines support
    • Human papillomavirus vaccine
    • Injection safety support
    • Measles second dose
    • Meningitis A vaccine
    • Pentavalent vaccine
    • Pneumococcal vaccine
    • Measles-Rubella vaccine
    • Rotavirus vaccine
    • Yellow fever vaccine
  • Immunisation services support
  • Health Systems Funding Platform
  • Health system strengthening
  • Civil society organisation
• Country hub
  • Afghanistan
  • Albania
  • Angola
  • Armenia
  • Azerbaijan
  • Bangladesh
  • Benin
  • Bhutan
  • Bolivia
  • Bosnia & Herzegovina
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Central African Republic (the)
  • Chad

  • China
  • Comoros
  • Congo
  • Congo, DR
  • Côte d’Ivoire
  • Cuba
  • Djibouti
  • Eritrea
  • Ethiopia
  • Gambia
  • Georgia
  • Ghana
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti

  • Honduras
  • India
  • Indonesia
  • Kenya
  • Kiribati
  • Korea, DPR
  • Kyrgyzstan
  • Lao PDR
  • Lesotho
  • Liberia
  • Madagascar
  • Malawi
  • Mali
  • Mauritania
  • Moldova
  • Mongolia

  • Mozambique
  • Myanmar
  • Nepal
  • Nicaragua
  • Niger
  • Nigeria
  • Pakistan
  • Papua New Guinea
  • Rwanda
  • Sao Tome and Principe
  • Senegal
  • Sierra Leone
  • Solomon Islands
  • Somalia
  • South Sudan
  • Sri Lanka

  • Sudan
  • Tajikistan
  • Tanzania, UR
  • Timor Leste
  • Togo
  • Turkmenistan
  • Uganda
  • Ukraine
  • Uzbekistan
  • Vietnam
  • Yemen
  • Zambia
  • Zimbabwe
• Funding & finance
  • Long-term financial commitments
  • How GAVI is funded
  • Key figures: donor contributions & pledges
  • Donor profiles
  • Financial reports
  • GAVI Matching Fund
    • How it works
    • Partners
  • International Finance Facility for Immunisation
  • Pneumococcal AMC
• Results & evidence
  • Measuring & evaluating performance
  • Goal-level indicators
    • Mission indicators
    • Vaccine goal indicators
    • Health systems goal indicators
    • Financing goal indicators
    • Market-shaping goal indicators
  • Countries approved for support
  • Disbursements by country
  • GAVI's evaluation studies
    • GAVI first evaluation report
    • GAVI second evaluation report
    • GAVI support to CSO evaluation
    • GAVI-Government of China Hepatitis B vaccination programme
    • Gender Policy evaluation
    • IFFIm evaluation
    • Pneumococcal AMC process and design
    • Other studies
  • GAVI Progress reports
• Library & news
  • Search by topic, country and programme
  • News
    • Press releases
    • Statements
    • Return on investment stories
    • GAVI features
    • Eyewitness
    • GAVI blogs
  • Audio-visual
  • Board & committee minutes
  • GAVI documents
    • Country documents
    • Evaluations
    • Financial reports
    • Guidelines and forms
    • Policies
    • Strategy
    • Supply and procurement
  • Publications
  • Events